 Endogenous Candida endophthalmitis intravenous anesthesia propofol Propofol intravenous anesthetic agent US Food Drug Administration October rapid acceptance widespread use June Disease Control clusters postsurgical infections use propofol clusters cases endogenous Candida albicans infections nonimmunocompromised patients undergone nonophthalmologic surgery propofol anesthesia investigation Disease Control infections patients due extrinsic contamination propofol preparation use hospital Ophthalmologists aware new potential source endogenous endophthalmitis